Bharat Biotech have announced that the indigenously developed Covid-19 vaccine Covaxin has showed a 77.3 per cent efficacy in its phase 3 trials.
The company...
India's indigenous Covid vaccine Covaxin has submitted its phase-3 clinical trial data to World Health Organization (WHO) for its authorization. According to a report,...
Amid criticism on its liberalised vaccine policy, the Centre on Saturday said the media reports suggesting inequities in the distribution of doses were “inaccurate...
The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture the Sputnik V Covid-19...
While some countries are preparing to resume global travel, some people are discovering that their choice of vaccine could determine where they’re allowed to...
Ahmedabad-based Zydus Cadila can become India’s second indigenously-developed jab after Bharat Biotech’s Covaxin and fourth vaccine candidate as they are likely to apply for...
Covaxin has been found to be effective against coronavirus strains found in India and the UK, said Bharat Biotech on Sunday.
Citing a study published...
